These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 3025537)
1. Anatomical localization of corticotropin-releasing activity in the human brain. Favrod-Coune CA; Gaillard RC; Langevin H; Jaquier MC; Dolci W; Muller AF Life Sci; 1986 Dec; 39(25):2475-81. PubMed ID: 3025537 [TBL] [Abstract][Full Text] [Related]
2. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei. Ogilvie KM; Lee S; Rivier C Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416 [TBL] [Abstract][Full Text] [Related]
3. Involvement of rat corticotrophin-releasing factor-41-related peptide and vasopressin in adrenocorticotrophin-releasing activity from superfused rat hypothalami in vitro. Gillies G; Puri A; Hodgkinson S; Lowry PJ J Endocrinol; 1984 Oct; 103(1):25-9. PubMed ID: 6090571 [TBL] [Abstract][Full Text] [Related]
4. A different distribution of corticotropin releasing factor and arginine vasopressin contents in the hypothalamic nuclei after estrogen administration. Hashimoto K; Ohno N; Aoki Y; Kageyama J; Takahara J; Ofuji T Acta Med Okayama; 1981 Feb; 35(1):37-43. PubMed ID: 6266205 [TBL] [Abstract][Full Text] [Related]
5. Arginine vasopressin (AVP) depletion in neurons of the suprachiasmatic nuclei affects the AVP content of the paraventricular neurons and stimulates adrenocorticotrophic hormone release. Gomez F; Chapleur M; Fernette B; Burlet C; Nicolas JP; Burlet A J Neurosci Res; 1997 Nov; 50(4):565-74. PubMed ID: 9404718 [TBL] [Abstract][Full Text] [Related]
6. Localization of vasopressin in the rat brain. Hawthorn J; Ang VT; Jenkins JS Brain Res; 1980 Sep; 197(1):75-81. PubMed ID: 7397564 [TBL] [Abstract][Full Text] [Related]
7. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action. Spinedi E; Giacomini M; Jacquier MC; Gaillard RC Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620 [TBL] [Abstract][Full Text] [Related]
8. Anatomical Localization of Corticotropin-Releasing Factor and Arginine Vasopressin in the Human Hypothalamus; the Effect of Corticosteroids on their Concentrations in Human and Rat Hypothalami. Pralong FP; Linton EA; Favrod-Coune CA; Lowry PJ; Muller AF; Gaillard RC J Neuroendocrinol; 1990 Jun; 2(3):369-74. PubMed ID: 19215362 [TBL] [Abstract][Full Text] [Related]
9. Distribution and characterization of corticotropin-releasing factor and arginine vasopressin in rat hypothalamic nuclei. Hashimoto K; Ohno N; Aoki Y; Kageyama J; Takahara J; Ofuji T Neuroendocrinology; 1982 Jan; 34(1):32-7. PubMed ID: 6977102 [TBL] [Abstract][Full Text] [Related]
10. Neuropeptide cells and fibers in the hypothalamus and pituitary of the fetal sheep: comparison of oxytocin and arginine vasopressin. Hoffman GE; McDonald T; Figueroa JP; Nathanielsz PW Neuroendocrinology; 1989 Dec; 50(6):633-43. PubMed ID: 2515463 [TBL] [Abstract][Full Text] [Related]
11. Corticotrophin-releasing factors in the hypothalamus of the developing fetal sheep. Currie IS; Brooks AN J Dev Physiol; 1992 May; 17(5):241-6. PubMed ID: 1281183 [TBL] [Abstract][Full Text] [Related]
12. The effects of estrogen and progesterone on corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey. Roy BN; Reid RL; Van Vugt DA Endocrinology; 1999 May; 140(5):2191-8. PubMed ID: 10218971 [TBL] [Abstract][Full Text] [Related]
13. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis. Chowdrey HS; Larsen PJ; Harbuz MS; Jessop DS; Aguilera G; Eckland DJ; Lightman SL Br J Pharmacol; 1995 Nov; 116(5):2417-24. PubMed ID: 8581278 [TBL] [Abstract][Full Text] [Related]
14. Central bombesin activates the hypothalamic-pituitary-adrenal axis. Effects on regional levels and release of corticotropin-releasing hormone and arginine-vasopressin. Kent P; Anisman H; Merali Z Neuroendocrinology; 2001 Mar; 73(3):203-14. PubMed ID: 11307039 [TBL] [Abstract][Full Text] [Related]
16. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia. Engler D; Pham T; Fullerton MJ; Ooi G; Funder JW; Clarke IJ Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360 [TBL] [Abstract][Full Text] [Related]
17. Hypotensive hemorrhage elevates corticotropin-releasing hormone messenger ribonucleic acid (mRNA) but not vasopressin mRNA in the rat hypothalamus. Darlington DN; Barraclough CA; Gann DS Endocrinology; 1992 Mar; 130(3):1281-8. PubMed ID: 1311234 [TBL] [Abstract][Full Text] [Related]
18. Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat. Calogero AE; Liapi C; Chrousos GP J Endocrinol Invest; 1991 Apr; 14(4):277-86. PubMed ID: 1650804 [TBL] [Abstract][Full Text] [Related]
19. IL-1 beta potentiates the acetylcholine-induced release of vasopressin from the hypothalamus in vitro, but not from the amygdala. Raber J; Pich EM; Koob GF; Bloom FE Neuroendocrinology; 1994 Mar; 59(3):208-17. PubMed ID: 8159270 [TBL] [Abstract][Full Text] [Related]
20. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Scott LV; Dinan TG Life Sci; 1998; 62(22):1985-98. PubMed ID: 9627097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]